Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HIC2
|
ENSG00000169635.5 | HIC ZBTB transcriptional repressor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HIC2 | hg19_v2_chr22_+_21771656_21771693 | -0.44 | 1.3e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_8073705 | 5.59 |
ENST00000514025.1
|
ABLIM2
|
actin binding LIM protein family, member 2 |
chr6_-_33714752 | 5.58 |
ENST00000451316.1
|
IP6K3
|
inositol hexakisphosphate kinase 3 |
chr8_-_75233563 | 5.45 |
ENST00000342232.4
|
JPH1
|
junctophilin 1 |
chr1_-_120311517 | 5.40 |
ENST00000369406.3
ENST00000544913.2 |
HMGCS2
|
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
chr11_-_118550375 | 4.89 |
ENST00000525958.1
ENST00000264029.4 ENST00000397925.1 ENST00000529101.1 |
TREH
|
trehalase (brush-border membrane glycoprotein) |
chr5_-_142065223 | 4.61 |
ENST00000378046.1
|
FGF1
|
fibroblast growth factor 1 (acidic) |
chr20_+_36974759 | 4.45 |
ENST00000217407.2
|
LBP
|
lipopolysaccharide binding protein |
chr4_-_8073554 | 4.40 |
ENST00000510277.1
|
ABLIM2
|
actin binding LIM protein family, member 2 |
chr15_+_51633826 | 4.32 |
ENST00000335449.6
|
GLDN
|
gliomedin |
chr22_-_18923655 | 4.24 |
ENST00000438924.1
ENST00000457083.1 ENST00000420436.1 ENST00000334029.2 ENST00000357068.6 |
PRODH
|
proline dehydrogenase (oxidase) 1 |
chr9_+_87285539 | 3.89 |
ENST00000359847.3
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr3_+_148457585 | 3.89 |
ENST00000402260.1
|
AGTR1
|
angiotensin II receptor, type 1 |
chr11_+_27062502 | 3.71 |
ENST00000263182.3
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr12_-_7244469 | 3.60 |
ENST00000538050.1
ENST00000536053.2 |
C1R
|
complement component 1, r subcomponent |
chr11_+_27062272 | 3.56 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chrX_+_70435044 | 3.56 |
ENST00000374029.1
ENST00000374022.3 ENST00000447581.1 |
GJB1
|
gap junction protein, beta 1, 32kDa |
chr6_-_33714667 | 3.51 |
ENST00000293756.4
|
IP6K3
|
inositol hexakisphosphate kinase 3 |
chr16_+_55522536 | 3.41 |
ENST00000570283.1
|
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
chr12_+_120031264 | 3.39 |
ENST00000426426.1
|
TMEM233
|
transmembrane protein 233 |
chr12_+_50497784 | 3.37 |
ENST00000548814.1
|
GPD1
|
glycerol-3-phosphate dehydrogenase 1 (soluble) |
chr22_+_33197683 | 3.34 |
ENST00000266085.6
|
TIMP3
|
TIMP metallopeptidase inhibitor 3 |
chr12_-_7245125 | 3.33 |
ENST00000542285.1
ENST00000540610.1 |
C1R
|
complement component 1, r subcomponent |
chr19_+_50691437 | 3.28 |
ENST00000598205.1
|
MYH14
|
myosin, heavy chain 14, non-muscle |
chr9_+_87285257 | 3.25 |
ENST00000323115.4
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr4_-_186733363 | 3.23 |
ENST00000393523.2
ENST00000393528.3 ENST00000449407.2 |
SORBS2
|
sorbin and SH3 domain containing 2 |
chr9_+_133978190 | 3.19 |
ENST00000372312.3
|
AIF1L
|
allograft inflammatory factor 1-like |
chr9_+_87284675 | 3.17 |
ENST00000376208.1
ENST00000304053.6 ENST00000277120.3 |
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr12_+_53443963 | 3.17 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr12_-_7245018 | 3.05 |
ENST00000543835.1
ENST00000535233.2 |
C1R
|
complement component 1, r subcomponent |
chr16_-_75300679 | 2.96 |
ENST00000420641.3
|
BCAR1
|
breast cancer anti-estrogen resistance 1 |
chr7_+_37960163 | 2.89 |
ENST00000199448.4
ENST00000559325.1 ENST00000423717.1 |
EPDR1
|
ependymin related 1 |
chr1_+_160085501 | 2.88 |
ENST00000361216.3
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chrX_+_43515467 | 2.86 |
ENST00000338702.3
ENST00000542639.1 |
MAOA
|
monoamine oxidase A |
chr3_+_159570722 | 2.85 |
ENST00000482804.1
|
SCHIP1
|
schwannomin interacting protein 1 |
chr14_-_30396948 | 2.84 |
ENST00000331968.5
|
PRKD1
|
protein kinase D1 |
chr4_+_183164574 | 2.82 |
ENST00000511685.1
|
TENM3
|
teneurin transmembrane protein 3 |
chrX_-_43741594 | 2.81 |
ENST00000536181.1
ENST00000378069.4 |
MAOB
|
monoamine oxidase B |
chr11_-_2162468 | 2.75 |
ENST00000434045.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr3_-_10547192 | 2.72 |
ENST00000360273.2
ENST00000343816.4 |
ATP2B2
|
ATPase, Ca++ transporting, plasma membrane 2 |
chr11_+_1940925 | 2.69 |
ENST00000453458.1
ENST00000381557.2 ENST00000381589.3 ENST00000381579.3 ENST00000381563.4 ENST00000344578.4 |
TNNT3
|
troponin T type 3 (skeletal, fast) |
chr20_-_62129163 | 2.67 |
ENST00000298049.7
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
chr12_+_53443680 | 2.65 |
ENST00000314250.6
ENST00000451358.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr14_-_35183886 | 2.58 |
ENST00000298159.6
|
CFL2
|
cofilin 2 (muscle) |
chr12_-_7245080 | 2.57 |
ENST00000541042.1
ENST00000540242.1 |
C1R
|
complement component 1, r subcomponent |
chr18_+_12254318 | 2.57 |
ENST00000320477.9
|
CIDEA
|
cell death-inducing DFFA-like effector a |
chr10_-_61122220 | 2.54 |
ENST00000422313.2
ENST00000435852.2 ENST00000442566.3 ENST00000373868.2 ENST00000277705.6 ENST00000373867.3 ENST00000419214.2 |
FAM13C
|
family with sequence similarity 13, member C |
chr8_+_67344710 | 2.54 |
ENST00000379385.4
ENST00000396623.3 ENST00000415254.1 |
ADHFE1
|
alcohol dehydrogenase, iron containing, 1 |
chr12_-_323248 | 2.54 |
ENST00000535347.1
ENST00000536824.1 |
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter), member 12 |
chr16_+_66400533 | 2.51 |
ENST00000341529.3
|
CDH5
|
cadherin 5, type 2 (vascular endothelium) |
chr19_+_35532612 | 2.50 |
ENST00000600390.1
ENST00000597419.1 |
HPN
|
hepsin |
chr16_-_20364030 | 2.50 |
ENST00000396134.2
ENST00000573567.1 ENST00000570757.1 ENST00000424589.1 ENST00000302509.4 ENST00000571174.1 ENST00000576688.1 |
UMOD
|
uromodulin |
chr5_+_137774706 | 2.47 |
ENST00000378339.2
ENST00000254901.5 ENST00000506158.1 |
REEP2
|
receptor accessory protein 2 |
chr9_-_33402506 | 2.45 |
ENST00000377425.4
ENST00000537089.1 ENST00000297988.1 ENST00000539936.1 ENST00000541274.1 |
AQP7
|
aquaporin 7 |
chr10_+_124221036 | 2.43 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
chr9_-_34589700 | 2.40 |
ENST00000351266.4
|
CNTFR
|
ciliary neurotrophic factor receptor |
chr17_+_73717516 | 2.38 |
ENST00000200181.3
ENST00000339591.3 |
ITGB4
|
integrin, beta 4 |
chr8_-_110656995 | 2.35 |
ENST00000276646.9
ENST00000533065.1 |
SYBU
|
syntabulin (syntaxin-interacting) |
chr1_-_217250231 | 2.34 |
ENST00000493748.1
ENST00000463665.1 |
ESRRG
|
estrogen-related receptor gamma |
chr11_-_111783595 | 2.32 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
chr17_+_43971643 | 2.30 |
ENST00000344290.5
ENST00000262410.5 ENST00000351559.5 ENST00000340799.5 ENST00000535772.1 ENST00000347967.5 |
MAPT
|
microtubule-associated protein tau |
chr19_-_49658387 | 2.29 |
ENST00000595625.1
|
HRC
|
histidine rich calcium binding protein |
chr9_-_112260531 | 2.28 |
ENST00000374541.2
ENST00000262539.3 |
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3 |
chr1_-_203144941 | 2.28 |
ENST00000255416.4
|
MYBPH
|
myosin binding protein H |
chr1_+_160085567 | 2.28 |
ENST00000392233.3
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chr9_-_130635741 | 2.22 |
ENST00000223836.10
|
AK1
|
adenylate kinase 1 |
chr4_-_75719896 | 2.22 |
ENST00000395743.3
|
BTC
|
betacellulin |
chr1_+_159175201 | 2.18 |
ENST00000368121.2
|
DARC
|
Duffy blood group, atypical chemokine receptor |
chr9_-_34590121 | 2.17 |
ENST00000417345.1
|
CNTFR
|
ciliary neurotrophic factor receptor |
chr6_-_3227877 | 2.16 |
ENST00000259818.7
|
TUBB2B
|
tubulin, beta 2B class IIb |
chr6_+_43739697 | 2.16 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
chr2_+_105471969 | 2.15 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
chr9_-_34589734 | 2.14 |
ENST00000378980.3
|
CNTFR
|
ciliary neurotrophic factor receptor |
chr22_+_31518938 | 2.14 |
ENST00000412985.1
ENST00000331075.5 ENST00000412277.2 ENST00000420017.1 ENST00000400294.2 ENST00000405300.1 ENST00000404390.3 |
INPP5J
|
inositol polyphosphate-5-phosphatase J |
chr8_+_17354587 | 2.11 |
ENST00000494857.1
ENST00000522656.1 |
SLC7A2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
chrX_+_103029314 | 2.11 |
ENST00000429977.1
|
PLP1
|
proteolipid protein 1 |
chr8_+_17354617 | 2.10 |
ENST00000470360.1
|
SLC7A2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
chr3_+_148447887 | 2.10 |
ENST00000475347.1
ENST00000474935.1 ENST00000461609.1 |
AGTR1
|
angiotensin II receptor, type 1 |
chr3_+_46921732 | 2.10 |
ENST00000418619.1
|
PTH1R
|
parathyroid hormone 1 receptor |
chr3_+_16216210 | 2.09 |
ENST00000437509.1
|
GALNT15
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
chr10_-_97200772 | 2.09 |
ENST00000371241.1
ENST00000354106.3 ENST00000371239.1 ENST00000361941.3 ENST00000277982.5 ENST00000371245.3 |
SORBS1
|
sorbin and SH3 domain containing 1 |
chr14_-_35183755 | 2.09 |
ENST00000555765.1
|
CFL2
|
cofilin 2 (muscle) |
chr10_-_71169031 | 2.09 |
ENST00000373307.1
|
TACR2
|
tachykinin receptor 2 |
chr12_-_7245152 | 2.08 |
ENST00000542220.2
|
C1R
|
complement component 1, r subcomponent |
chr13_+_113633620 | 2.08 |
ENST00000421756.1
ENST00000375601.3 |
MCF2L
|
MCF.2 cell line derived transforming sequence-like |
chr1_+_201857798 | 2.08 |
ENST00000362011.6
|
SHISA4
|
shisa family member 4 |
chr19_-_17488143 | 2.08 |
ENST00000599426.1
ENST00000252590.4 |
PLVAP
|
plasmalemma vesicle associated protein |
chr12_-_56101647 | 2.06 |
ENST00000347027.6
ENST00000257879.6 ENST00000257880.7 ENST00000394230.2 ENST00000394229.2 |
ITGA7
|
integrin, alpha 7 |
chr14_-_30396802 | 2.05 |
ENST00000415220.2
|
PRKD1
|
protein kinase D1 |
chr5_+_150406527 | 2.04 |
ENST00000520059.1
|
GPX3
|
glutathione peroxidase 3 (plasma) |
chr6_-_39902185 | 2.04 |
ENST00000373195.3
ENST00000308559.7 ENST00000373188.2 |
MOCS1
|
molybdenum cofactor synthesis 1 |
chr1_+_32042131 | 2.03 |
ENST00000271064.7
ENST00000537531.1 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
chr18_+_29171689 | 2.03 |
ENST00000237014.3
|
TTR
|
transthyretin |
chr22_+_38864041 | 2.02 |
ENST00000216014.4
ENST00000409006.3 |
KDELR3
|
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 |
chr19_+_13122980 | 2.01 |
ENST00000590027.1
|
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
chr15_+_63050785 | 2.01 |
ENST00000472902.1
|
TLN2
|
talin 2 |
chr9_+_87284622 | 2.00 |
ENST00000395882.1
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr17_+_79990058 | 2.00 |
ENST00000584341.1
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
chrX_+_37208521 | 2.00 |
ENST00000378628.4
|
PRRG1
|
proline rich Gla (G-carboxyglutamic acid) 1 |
chr1_-_33336414 | 1.99 |
ENST00000373471.3
ENST00000609187.1 |
FNDC5
|
fibronectin type III domain containing 5 |
chr1_-_217262933 | 1.98 |
ENST00000359162.2
|
ESRRG
|
estrogen-related receptor gamma |
chr16_-_20364122 | 1.96 |
ENST00000396138.4
ENST00000577168.1 |
UMOD
|
uromodulin |
chr20_+_43029911 | 1.96 |
ENST00000443598.2
ENST00000316099.4 ENST00000415691.2 |
HNF4A
|
hepatocyte nuclear factor 4, alpha |
chr16_-_66952779 | 1.95 |
ENST00000570262.1
ENST00000394055.3 ENST00000299752.4 |
CDH16
|
cadherin 16, KSP-cadherin |
chr3_+_16216137 | 1.95 |
ENST00000339732.5
|
GALNT15
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
chr6_-_39902160 | 1.93 |
ENST00000340692.5
|
MOCS1
|
molybdenum cofactor synthesis 1 |
chr7_+_30960915 | 1.92 |
ENST00000441328.2
ENST00000409899.1 ENST00000409611.1 |
AQP1
|
aquaporin 1 (Colton blood group) |
chr12_-_15038779 | 1.90 |
ENST00000228938.5
ENST00000539261.1 |
MGP
|
matrix Gla protein |
chr11_+_57310114 | 1.90 |
ENST00000527972.1
ENST00000399154.2 |
SMTNL1
|
smoothelin-like 1 |
chr11_+_17756279 | 1.89 |
ENST00000265969.6
|
KCNC1
|
potassium voltage-gated channel, Shaw-related subfamily, member 1 |
chr14_+_96671016 | 1.89 |
ENST00000542454.2
ENST00000554311.1 ENST00000306005.3 ENST00000539359.1 ENST00000553811.1 |
BDKRB2
RP11-404P21.8
|
bradykinin receptor B2 Uncharacterized protein |
chr10_-_95360983 | 1.89 |
ENST00000371464.3
|
RBP4
|
retinol binding protein 4, plasma |
chr7_+_134212312 | 1.88 |
ENST00000359579.4
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase) |
chr7_-_95225768 | 1.88 |
ENST00000005178.5
|
PDK4
|
pyruvate dehydrogenase kinase, isozyme 4 |
chr5_-_173217916 | 1.87 |
ENST00000523617.1
|
CTB-43E15.4
|
CTB-43E15.4 |
chr10_+_115312766 | 1.86 |
ENST00000351270.3
|
HABP2
|
hyaluronan binding protein 2 |
chr5_+_149980622 | 1.86 |
ENST00000394243.1
|
SYNPO
|
synaptopodin |
chr18_-_24445729 | 1.86 |
ENST00000383168.4
|
AQP4
|
aquaporin 4 |
chr1_-_24438664 | 1.85 |
ENST00000374434.3
ENST00000330966.7 ENST00000329601.7 |
MYOM3
|
myomesin 3 |
chr6_-_46922659 | 1.85 |
ENST00000265417.7
|
GPR116
|
G protein-coupled receptor 116 |
chr19_-_58485895 | 1.85 |
ENST00000314391.3
|
C19orf18
|
chromosome 19 open reading frame 18 |
chr19_+_46801639 | 1.85 |
ENST00000244303.6
ENST00000339613.2 ENST00000533145.1 ENST00000472815.1 |
HIF3A
|
hypoxia inducible factor 3, alpha subunit |
chr17_-_19619917 | 1.84 |
ENST00000325411.5
ENST00000350657.5 ENST00000433844.2 |
SLC47A2
|
solute carrier family 47 (multidrug and toxin extrusion), member 2 |
chr17_+_4487816 | 1.84 |
ENST00000389313.4
|
SMTNL2
|
smoothelin-like 2 |
chr11_-_2170786 | 1.83 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr16_+_3162557 | 1.83 |
ENST00000382192.3
ENST00000219091.4 ENST00000444510.2 ENST00000414351.1 |
ZNF205
|
zinc finger protein 205 |
chr15_-_74659978 | 1.83 |
ENST00000541301.1
ENST00000416978.1 ENST00000268053.6 |
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1 |
chr7_-_100491854 | 1.82 |
ENST00000426415.1
ENST00000430554.1 ENST00000412389.1 |
ACHE
|
acetylcholinesterase (Yt blood group) |
chr4_-_101111615 | 1.80 |
ENST00000273990.2
|
DDIT4L
|
DNA-damage-inducible transcript 4-like |
chr12_-_49393092 | 1.80 |
ENST00000421952.2
|
DDN
|
dendrin |
chr2_-_200320768 | 1.80 |
ENST00000428695.1
|
SATB2
|
SATB homeobox 2 |
chr12_+_31079652 | 1.79 |
ENST00000546076.1
ENST00000535215.1 ENST00000544427.1 ENST00000261177.9 |
TSPAN11
|
tetraspanin 11 |
chr16_-_51185172 | 1.79 |
ENST00000251020.4
|
SALL1
|
spalt-like transcription factor 1 |
chr11_-_2162162 | 1.78 |
ENST00000381389.1
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr17_+_73717551 | 1.78 |
ENST00000450894.3
|
ITGB4
|
integrin, beta 4 |
chr6_-_55443831 | 1.78 |
ENST00000428842.1
ENST00000358072.5 ENST00000508459.1 |
HMGCLL1
|
3-hydroxymethyl-3-methylglutaryl-CoA lyase-like 1 |
chr19_-_51017881 | 1.77 |
ENST00000601207.1
ENST00000598657.1 ENST00000376916.3 |
ASPDH
|
aspartate dehydrogenase domain containing |
chr9_+_132962843 | 1.76 |
ENST00000458469.1
|
NCS1
|
neuronal calcium sensor 1 |
chr4_-_6383594 | 1.75 |
ENST00000335585.5
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma |
chr2_+_153191706 | 1.75 |
ENST00000288670.9
|
FMNL2
|
formin-like 2 |
chrX_-_153151586 | 1.75 |
ENST00000370060.1
ENST00000370055.1 ENST00000420165.1 |
L1CAM
|
L1 cell adhesion molecule |
chr4_-_186732892 | 1.74 |
ENST00000451958.1
ENST00000439914.1 ENST00000428330.1 ENST00000429056.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
chr8_+_49984894 | 1.74 |
ENST00000522267.1
ENST00000399653.4 ENST00000303202.8 |
C8orf22
|
chromosome 8 open reading frame 22 |
chr11_-_61348292 | 1.74 |
ENST00000539008.1
ENST00000540677.1 ENST00000542836.1 ENST00000542670.1 ENST00000535826.1 ENST00000545053.1 |
SYT7
|
synaptotagmin VII |
chr4_+_2061119 | 1.74 |
ENST00000423729.2
|
NAT8L
|
N-acetyltransferase 8-like (GCN5-related, putative) |
chr17_-_15168624 | 1.73 |
ENST00000312280.3
ENST00000494511.1 ENST00000580584.1 |
PMP22
|
peripheral myelin protein 22 |
chr17_+_73717407 | 1.72 |
ENST00000579662.1
|
ITGB4
|
integrin, beta 4 |
chr14_-_21489271 | 1.72 |
ENST00000553593.1
|
NDRG2
|
NDRG family member 2 |
chr11_-_118023490 | 1.72 |
ENST00000324727.4
|
SCN4B
|
sodium channel, voltage-gated, type IV, beta subunit |
chr1_+_32042105 | 1.71 |
ENST00000457433.2
ENST00000441210.2 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
chr1_-_214638146 | 1.71 |
ENST00000543945.1
|
PTPN14
|
protein tyrosine phosphatase, non-receptor type 14 |
chr1_-_217262969 | 1.71 |
ENST00000361525.3
|
ESRRG
|
estrogen-related receptor gamma |
chr12_+_50344516 | 1.70 |
ENST00000199280.3
ENST00000550862.1 |
AQP2
|
aquaporin 2 (collecting duct) |
chr6_-_56707943 | 1.70 |
ENST00000370769.4
ENST00000421834.2 ENST00000312431.6 ENST00000361203.3 ENST00000523817.1 |
DST
|
dystonin |
chr11_+_116700600 | 1.70 |
ENST00000227667.3
|
APOC3
|
apolipoprotein C-III |
chr15_+_96875657 | 1.70 |
ENST00000559679.1
ENST00000394171.2 |
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr11_+_1940786 | 1.68 |
ENST00000278317.6
ENST00000381561.4 ENST00000381548.3 ENST00000360603.3 ENST00000381549.3 |
TNNT3
|
troponin T type 3 (skeletal, fast) |
chr16_+_57481349 | 1.68 |
ENST00000262507.6
ENST00000565964.1 |
COQ9
|
coenzyme Q9 |
chr1_-_237167718 | 1.68 |
ENST00000464121.2
|
MT1HL1
|
metallothionein 1H-like 1 |
chr8_-_110704014 | 1.68 |
ENST00000529190.1
ENST00000422135.1 ENST00000419099.1 |
SYBU
|
syntabulin (syntaxin-interacting) |
chr11_-_68780824 | 1.67 |
ENST00000441623.1
ENST00000309099.6 |
MRGPRF
|
MAS-related GPR, member F |
chr8_-_110703819 | 1.67 |
ENST00000532779.1
ENST00000534578.1 |
SYBU
|
syntabulin (syntaxin-interacting) |
chr16_-_66952742 | 1.66 |
ENST00000565235.2
ENST00000568632.1 ENST00000565796.1 |
CDH16
|
cadherin 16, KSP-cadherin |
chr6_-_55443975 | 1.66 |
ENST00000308161.4
ENST00000398661.2 ENST00000274901.4 |
HMGCLL1
|
3-hydroxymethyl-3-methylglutaryl-CoA lyase-like 1 |
chr1_-_151345159 | 1.66 |
ENST00000458566.1
ENST00000447402.3 ENST00000426705.2 ENST00000435071.1 ENST00000368868.5 |
SELENBP1
|
selenium binding protein 1 |
chr2_-_11810284 | 1.66 |
ENST00000306928.5
|
NTSR2
|
neurotensin receptor 2 |
chr17_+_43972010 | 1.66 |
ENST00000334239.8
ENST00000446361.3 |
MAPT
|
microtubule-associated protein tau |
chr11_-_2158507 | 1.63 |
ENST00000381392.1
ENST00000381395.1 ENST00000418738.2 |
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr1_+_156096336 | 1.63 |
ENST00000504687.1
ENST00000473598.2 |
LMNA
|
lamin A/C |
chr1_+_205473865 | 1.63 |
ENST00000506215.1
ENST00000419301.1 |
CDK18
|
cyclin-dependent kinase 18 |
chr10_-_123274693 | 1.63 |
ENST00000429361.1
|
FGFR2
|
fibroblast growth factor receptor 2 |
chr7_+_107301447 | 1.62 |
ENST00000440056.1
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4 |
chr1_-_147245445 | 1.61 |
ENST00000430508.1
|
GJA5
|
gap junction protein, alpha 5, 40kDa |
chrX_-_137793826 | 1.61 |
ENST00000315930.6
|
FGF13
|
fibroblast growth factor 13 |
chr9_+_33750515 | 1.61 |
ENST00000361005.5
|
PRSS3
|
protease, serine, 3 |
chr7_+_79764104 | 1.60 |
ENST00000351004.3
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
chr2_+_234637754 | 1.60 |
ENST00000482026.1
ENST00000609767.1 |
UGT1A3
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A3 UDP glucuronosyltransferase 1 family, polypeptide A8 |
chr2_-_88427568 | 1.59 |
ENST00000393750.3
ENST00000295834.3 |
FABP1
|
fatty acid binding protein 1, liver |
chr1_-_8075693 | 1.59 |
ENST00000467067.1
|
ERRFI1
|
ERBB receptor feedback inhibitor 1 |
chr9_-_104249400 | 1.59 |
ENST00000374848.3
|
TMEM246
|
transmembrane protein 246 |
chr16_+_2083265 | 1.59 |
ENST00000565855.1
ENST00000566198.1 |
SLC9A3R2
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 |
chr3_-_48471454 | 1.58 |
ENST00000296440.6
ENST00000448774.2 |
PLXNB1
|
plexin B1 |
chr10_-_13544945 | 1.58 |
ENST00000378605.3
ENST00000341083.3 |
BEND7
|
BEN domain containing 7 |
chr18_-_48346415 | 1.58 |
ENST00000431965.2
ENST00000436348.2 |
MRO
|
maestro |
chr5_-_87980587 | 1.58 |
ENST00000509783.1
ENST00000509405.1 ENST00000506978.1 ENST00000509265.1 ENST00000513805.1 |
LINC00461
|
long intergenic non-protein coding RNA 461 |
chr17_-_15165854 | 1.57 |
ENST00000395936.1
ENST00000395938.2 |
PMP22
|
peripheral myelin protein 22 |
chr16_-_75301886 | 1.57 |
ENST00000393422.2
|
BCAR1
|
breast cancer anti-estrogen resistance 1 |
chr9_-_93405352 | 1.56 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
chr22_+_51112800 | 1.56 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
chr1_+_233765353 | 1.56 |
ENST00000366620.1
|
KCNK1
|
potassium channel, subfamily K, member 1 |
chr11_-_118550346 | 1.55 |
ENST00000530256.1
|
TREH
|
trehalase (brush-border membrane glycoprotein) |
chr17_+_7557414 | 1.55 |
ENST00000577113.1
|
ATP1B2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
chr1_-_168698433 | 1.55 |
ENST00000367817.3
|
DPT
|
dermatopontin |
chr11_-_8739383 | 1.54 |
ENST00000531060.1
|
ST5
|
suppression of tumorigenicity 5 |
chr13_-_78492927 | 1.54 |
ENST00000334286.5
|
EDNRB
|
endothelin receptor type B |
chr1_+_205473784 | 1.54 |
ENST00000478560.1
ENST00000443813.2 |
CDK18
|
cyclin-dependent kinase 18 |
chr11_-_63933504 | 1.53 |
ENST00000255681.6
|
MACROD1
|
MACRO domain containing 1 |
chr17_-_39928106 | 1.53 |
ENST00000540235.1
|
JUP
|
junction plakoglobin |
chr9_-_129884902 | 1.52 |
ENST00000373417.1
|
ANGPTL2
|
angiopoietin-like 2 |
chr17_+_41005283 | 1.52 |
ENST00000592999.1
|
AOC3
|
amine oxidase, copper containing 3 |
chr5_+_76248538 | 1.52 |
ENST00000274368.4
|
CRHBP
|
corticotropin releasing hormone binding protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 12.3 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
1.7 | 5.2 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
1.6 | 4.9 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
1.5 | 1.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
1.5 | 6.0 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
1.5 | 4.4 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
1.4 | 4.2 | GO:0061461 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
1.3 | 6.6 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
1.2 | 3.5 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
1.1 | 3.2 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
1.0 | 2.9 | GO:0086055 | atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
0.9 | 3.6 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.9 | 3.5 | GO:0060254 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
0.8 | 2.5 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.8 | 3.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.8 | 7.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.8 | 2.4 | GO:0097187 | dentinogenesis(GO:0097187) |
0.7 | 2.2 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
0.7 | 8.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.7 | 2.9 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.7 | 4.2 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
0.7 | 12.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.7 | 2.7 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.7 | 3.4 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.7 | 4.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.6 | 0.6 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.6 | 6.9 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.6 | 3.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.6 | 2.5 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.6 | 1.9 | GO:0016488 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
0.6 | 2.5 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.6 | 3.7 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.6 | 3.0 | GO:0008050 | female courtship behavior(GO:0008050) |
0.6 | 1.8 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.6 | 1.8 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.6 | 2.9 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.6 | 2.3 | GO:0048242 | regulation of epinephrine secretion(GO:0014060) epinephrine secretion(GO:0048242) |
0.6 | 7.3 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.6 | 2.2 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.6 | 2.2 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.5 | 3.3 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.5 | 2.2 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.5 | 1.6 | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
0.5 | 1.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.5 | 2.7 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.5 | 2.7 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.5 | 3.2 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.5 | 2.1 | GO:1904647 | response to rotenone(GO:1904647) |
0.5 | 2.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.5 | 1.0 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.5 | 1.5 | GO:0007497 | posterior midgut development(GO:0007497) endothelin receptor signaling pathway(GO:0086100) |
0.5 | 2.5 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.5 | 1.5 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.5 | 1.5 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.5 | 1.4 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.5 | 1.4 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 1.4 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.5 | 0.5 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.5 | 2.4 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.5 | 0.5 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.5 | 2.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.5 | 2.3 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.5 | 5.9 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.5 | 2.3 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.5 | 1.8 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.5 | 1.8 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.4 | 6.7 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.4 | 1.3 | GO:1901383 | negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
0.4 | 1.8 | GO:0060921 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) |
0.4 | 1.7 | GO:0009956 | radial pattern formation(GO:0009956) |
0.4 | 1.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 2.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.4 | 1.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.4 | 2.5 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.4 | 0.4 | GO:0044335 | canonical Wnt signaling pathway involved in neural crest cell differentiation(GO:0044335) |
0.4 | 6.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 1.2 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.4 | 2.5 | GO:0015793 | glycerol transport(GO:0015793) |
0.4 | 2.0 | GO:0060460 | subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) prolactin secreting cell differentiation(GO:0060127) left lung morphogenesis(GO:0060460) superior vena cava morphogenesis(GO:0060578) |
0.4 | 1.2 | GO:0034059 | response to anoxia(GO:0034059) |
0.4 | 3.2 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.4 | 1.2 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
0.4 | 2.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.4 | 1.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.4 | 1.6 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.4 | 2.8 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) regulation of muscle filament sliding(GO:0032971) |
0.4 | 1.2 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.4 | 2.0 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 0.8 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.4 | 1.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.4 | 2.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.4 | 1.8 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.4 | 2.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.4 | 0.7 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.4 | 1.1 | GO:0061055 | myotome development(GO:0061055) |
0.4 | 4.0 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.4 | 2.9 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.4 | 5.4 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.4 | 7.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.4 | 0.4 | GO:0008585 | female gonad development(GO:0008585) development of primary female sexual characteristics(GO:0046545) |
0.4 | 1.8 | GO:0003095 | pressure natriuresis(GO:0003095) |
0.4 | 2.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.3 | 1.7 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.3 | 1.0 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.3 | 2.9 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
0.3 | 0.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 4.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 1.3 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.3 | 3.4 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.3 | 2.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 6.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 5.3 | GO:0035878 | nail development(GO:0035878) |
0.3 | 1.8 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 1.8 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.3 | 2.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.3 | 1.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 0.6 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.3 | 0.9 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.3 | 6.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 0.3 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.3 | 1.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 0.9 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.3 | 0.6 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.3 | 2.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 0.3 | GO:0001508 | action potential(GO:0001508) |
0.3 | 0.8 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.3 | 1.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.3 | 0.8 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.3 | 6.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.3 | 1.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.3 | 1.1 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.3 | 0.8 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.3 | 0.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 1.6 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.3 | 0.8 | GO:0048627 | myoblast development(GO:0048627) |
0.3 | 0.5 | GO:0009450 | gamma-aminobutyric acid catabolic process(GO:0009450) |
0.3 | 1.8 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.3 | 0.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.3 | 1.3 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.3 | 2.1 | GO:0060627 | regulation of vesicle-mediated transport(GO:0060627) |
0.3 | 1.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.3 | 0.8 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.3 | 5.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 2.3 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.3 | 2.0 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.2 | 2.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.2 | 1.0 | GO:0061053 | somite development(GO:0061053) |
0.2 | 1.0 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.2 | 1.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.2 | 1.0 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.2 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 0.7 | GO:0044209 | AMP salvage(GO:0044209) |
0.2 | 4.0 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.2 | 0.7 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.2 | 1.6 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.2 | 1.2 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
0.2 | 1.9 | GO:0046618 | drug export(GO:0046618) |
0.2 | 1.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.2 | 1.4 | GO:0060214 | endocardium formation(GO:0060214) |
0.2 | 3.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 4.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.2 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
0.2 | 0.9 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
0.2 | 2.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.7 | GO:0072313 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.2 | 2.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.7 | GO:0010949 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.2 | 1.3 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.2 | 0.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.4 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.2 | 0.9 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.2 | 1.5 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.2 | 3.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.2 | 4.3 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.2 | 2.1 | GO:0015820 | leucine transport(GO:0015820) |
0.2 | 0.9 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
0.2 | 0.6 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
0.2 | 2.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 0.4 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 2.1 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.2 | 2.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 9.8 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.2 | 1.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 0.6 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 2.6 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.2 | 0.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 3.6 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.6 | GO:1904640 | response to methionine(GO:1904640) |
0.2 | 1.0 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.2 | 0.8 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.2 | 1.8 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.2 | 2.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 2.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 1.0 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.2 | 1.6 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.2 | 1.7 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.2 | 0.8 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 1.2 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.2 | 0.4 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.2 | 1.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.6 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 2.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 2.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.8 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.2 | 0.6 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 1.9 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 0.6 | GO:0008057 | eye pigment granule organization(GO:0008057) |
0.2 | 0.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.2 | 1.1 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.2 | 0.7 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.9 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.2 | 0.6 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.2 | 0.4 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.2 | 1.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 3.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 1.8 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 1.6 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.2 | 0.7 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.2 | 2.5 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
0.2 | 0.7 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.2 | 0.7 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.2 | 3.2 | GO:0006833 | water transport(GO:0006833) |
0.2 | 1.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 1.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 1.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 1.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 0.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 0.2 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.2 | 0.5 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.2 | 0.7 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 6.6 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 0.8 | GO:1903275 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.2 | 2.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 2.0 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.2 | 1.2 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.2 | 0.7 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.2 | 1.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 4.8 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 2.5 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 7.0 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 1.5 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.2 | 1.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.3 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.2 | 0.8 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.2 | 0.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.2 | 1.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.2 | 1.4 | GO:1901731 | protein secretion by platelet(GO:0070560) positive regulation of platelet aggregation(GO:1901731) |
0.2 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.3 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.2 | 0.6 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.2 | 0.3 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.2 | 0.2 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.2 | 1.7 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.2 | 1.5 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 1.2 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 1.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.9 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.1 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 5.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 2.0 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.4 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
0.1 | 2.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.6 | GO:0072237 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) metanephric proximal tubule development(GO:0072237) |
0.1 | 3.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.6 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 6.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 3.5 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 1.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.4 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.1 | 0.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.3 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.1 | 2.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 2.4 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.1 | 0.6 | GO:0097325 | chemoattraction of serotonergic neuron axon(GO:0036517) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) chemoattraction of axon(GO:0061642) melanocyte proliferation(GO:0097325) negative regulation of cell proliferation in midbrain(GO:1904934) planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation(GO:1904955) |
0.1 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 2.2 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.4 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.1 | 1.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 2.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 1.1 | GO:0015811 | L-cystine transport(GO:0015811) |
0.1 | 1.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.4 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.1 | 3.9 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 1.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.5 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 0.5 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 2.5 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 1.5 | GO:0035864 | response to potassium ion(GO:0035864) |
0.1 | 0.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 2.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.7 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.8 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.1 | 0.6 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.5 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
0.1 | 4.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 6.5 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 1.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 2.4 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.1 | 0.4 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.1 | 0.6 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.7 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 3.3 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.1 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 1.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.4 | GO:2000611 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) negative regulation of somatic stem cell population maintenance(GO:1904673) positive regulation of thyroid hormone generation(GO:2000611) |
0.1 | 1.0 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.5 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 1.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.5 | GO:2000381 | negative regulation of nodal signaling pathway(GO:1900108) negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.7 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 0.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 2.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 2.4 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.4 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 0.5 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 1.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 1.1 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.1 | 0.7 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 3.3 | GO:0007517 | muscle organ development(GO:0007517) |
0.1 | 0.4 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.1 | 0.7 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.3 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.6 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.1 | 1.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.7 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.2 | GO:0002537 | nitric oxide production involved in inflammatory response(GO:0002537) |
0.1 | 0.3 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
0.1 | 0.3 | GO:0042445 | hormone metabolic process(GO:0042445) |
0.1 | 1.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.4 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.1 | 1.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 1.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.8 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.2 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 1.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 1.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 1.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.8 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 1.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.7 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.8 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 1.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 1.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.1 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.1 | 0.3 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 2.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.8 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 6.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.3 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 2.1 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 3.3 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 1.3 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 1.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 1.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 2.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 2.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.7 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 0.4 | GO:0090301 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.1 | 1.7 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 1.0 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.1 | 3.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.7 | GO:0019075 | virus maturation(GO:0019075) |
0.1 | 0.4 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 0.3 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
0.1 | 2.1 | GO:0001502 | cartilage condensation(GO:0001502) |
0.1 | 0.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.1 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.4 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.1 | 0.6 | GO:1901909 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.1 | 0.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.8 | GO:0015822 | ornithine transport(GO:0015822) |
0.1 | 0.3 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 2.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 2.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.6 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 1.7 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.1 | 1.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.4 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.5 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.5 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
0.1 | 0.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 1.9 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 1.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 1.1 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.7 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.7 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 4.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.4 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.1 | 3.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 1.2 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.9 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.8 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.1 | 0.3 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.7 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.1 | 0.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.2 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.1 | 1.1 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.1 | 0.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 3.0 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.1 | 0.3 | GO:1901805 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
0.1 | 0.2 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
0.1 | 0.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 1.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.9 | GO:0006364 | rRNA processing(GO:0006364) rRNA metabolic process(GO:0016072) |
0.1 | 0.6 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.1 | 0.3 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.1 | 3.4 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 1.7 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.2 | GO:0035573 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.4 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.7 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 0.6 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.3 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 0.4 | GO:0050918 | positive chemotaxis(GO:0050918) |
0.1 | 4.4 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.7 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 1.1 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.1 | 0.6 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.3 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.8 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.1 | 0.7 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.1 | 1.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
0.1 | 0.3 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.1 | 4.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 1.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.9 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.5 | GO:0019216 | regulation of lipid metabolic process(GO:0019216) |
0.1 | 0.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 1.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.3 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 1.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 3.7 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.1 | 0.8 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
0.1 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.3 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.3 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 1.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 0.2 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.1 | 0.2 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.1 | 0.7 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.1 | 1.9 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 1.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 1.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 2.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.2 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.1 | 0.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.1 | 2.9 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 1.0 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.1 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.8 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 1.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 2.3 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.2 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.2 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 1.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.4 | GO:0061458 | reproductive system development(GO:0061458) |
0.1 | 1.3 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.2 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.1 | 0.4 | GO:0060137 | habituation(GO:0046959) negative regulation of growth hormone secretion(GO:0060125) maternal process involved in parturition(GO:0060137) |
0.1 | 0.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 0.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.3 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.1 | 0.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 1.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.8 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.1 | GO:0019516 | lactate oxidation(GO:0019516) |
0.0 | 0.7 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.8 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 1.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.1 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.0 | 0.7 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.3 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 1.1 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 0.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.4 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.3 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.0 | 0.3 | GO:0019474 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.0 | 1.1 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.7 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.0 | 0.3 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.0 | 1.3 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.0 | 0.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.4 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.3 | GO:0071902 | positive regulation of protein serine/threonine kinase activity(GO:0071902) |
0.0 | 0.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 2.4 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.4 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.2 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.0 | 1.0 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 | 1.4 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.6 | GO:0035272 | exocrine system development(GO:0035272) |
0.0 | 0.8 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.0 | 0.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.0 | 0.3 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus(GO:0035924) |
0.0 | 0.3 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.0 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 1.6 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 2.4 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.2 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
0.0 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.2 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.0 | 1.7 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.2 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.0 | 2.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.3 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.0 | 2.9 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.0 | 0.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 1.3 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.3 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 1.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:1902680 | positive regulation of RNA biosynthetic process(GO:1902680) |
0.0 | 0.3 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.3 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.0 | 0.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.0 | 1.1 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 1.3 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 1.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.4 | GO:0044344 | cellular response to fibroblast growth factor stimulus(GO:0044344) |
0.0 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.7 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 3.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.5 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.5 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.3 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.0 | 2.2 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.1 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
0.0 | 0.9 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 1.1 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.6 | GO:0090278 | negative regulation of insulin secretion(GO:0046676) negative regulation of peptide hormone secretion(GO:0090278) |
0.0 | 0.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.7 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.2 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.0 | 0.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.7 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.3 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.0 | 1.1 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.9 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.0 | 4.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:1904688 | adenosine to inosine editing(GO:0006382) regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.0 | 0.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.6 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.2 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.1 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.0 | 0.9 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.3 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.0 | 0.8 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 2.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.2 | GO:0015711 | organic anion transport(GO:0015711) |
0.0 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.1 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0007178) |
0.0 | 1.0 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 1.3 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.0 | 0.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.1 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.0 | 1.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 2.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 3.4 | GO:0031638 | zymogen activation(GO:0031638) |
0.0 | 0.7 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.0 | GO:0072716 | response to actinomycin D(GO:0072716) |
0.0 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.1 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.1 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.0 | 0.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.2 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.5 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 0.2 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.2 | GO:0001701 | in utero embryonic development(GO:0001701) |
0.0 | 1.2 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.3 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.0 | GO:0060584 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.0 | 0.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.4 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 0.2 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.1 | GO:0016598 | protein arginylation(GO:0016598) |
0.0 | 0.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.2 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.1 | GO:0090287 | regulation of cellular response to growth factor stimulus(GO:0090287) |
0.0 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.3 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.1 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.5 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.3 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.0 | 0.5 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.6 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.2 | GO:0018394 | internal protein amino acid acetylation(GO:0006475) histone acetylation(GO:0016573) internal peptidyl-lysine acetylation(GO:0018393) peptidyl-lysine acetylation(GO:0018394) |
0.0 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 1.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.0 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 1.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.2 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.0 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 1.5 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 1.2 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.1 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.4 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.0 | 0.0 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.0 | 0.1 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.1 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.3 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 1.3 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.5 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.0 | 0.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.3 | GO:0007622 | rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
0.0 | 0.2 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.1 | GO:0072386 | plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0021510 | spinal cord development(GO:0021510) |
0.0 | 0.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.1 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.0 | 0.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.2 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.0 | 0.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 1.9 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.0 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.0 | 0.5 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.2 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.0 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.2 | GO:1902001 | fatty acid transmembrane transport(GO:1902001) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 4.0 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
1.3 | 3.8 | GO:0097444 | spine apparatus(GO:0097444) |
1.2 | 6.0 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.9 | 2.7 | GO:0043257 | laminin-8 complex(GO:0043257) |
0.8 | 4.7 | GO:0097513 | myosin II filament(GO:0097513) |
0.8 | 2.3 | GO:1990032 | parallel fiber(GO:1990032) |
0.7 | 4.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.6 | 1.9 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.6 | 3.4 | GO:0031673 | H zone(GO:0031673) |
0.6 | 4.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.5 | 6.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.5 | 1.4 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.5 | 4.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 2.2 | GO:0044393 | microspike(GO:0044393) |
0.4 | 1.7 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.4 | 2.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.4 | 1.5 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
0.4 | 2.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 10.1 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 3.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.3 | 1.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 8.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 5.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.3 | 2.7 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 3.8 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.3 | 4.8 | GO:0097433 | dense body(GO:0097433) |
0.3 | 5.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 2.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 2.7 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 1.0 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.3 | 0.8 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) integrin alphav-beta8 complex(GO:0034686) |
0.3 | 0.8 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.2 | 1.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 1.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.7 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 0.7 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.2 | 2.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.2 | 2.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 1.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 0.4 | GO:0044753 | amphisome(GO:0044753) |
0.2 | 5.1 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 5.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 1.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.2 | 2.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 3.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 1.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.0 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 1.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 1.4 | GO:0034448 | EGO complex(GO:0034448) |
0.2 | 0.8 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 1.5 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.0 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 2.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 2.7 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.9 | GO:0016938 | kinesin I complex(GO:0016938) |
0.2 | 1.4 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 5.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 1.5 | GO:0016528 | sarcoplasm(GO:0016528) |
0.2 | 2.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 2.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 2.0 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.8 | GO:0002133 | polycystin complex(GO:0002133) |
0.2 | 2.4 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.6 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 1.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 3.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 1.5 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 1.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 5.5 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 1.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 2.4 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 17.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.8 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.1 | 1.6 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 1.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 2.9 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 4.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.9 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 0.4 | GO:0098855 | HCN channel complex(GO:0098855) |
0.1 | 4.4 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.5 | GO:0045160 | myosin I complex(GO:0045160) |
0.1 | 1.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 6.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.6 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 6.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 3.1 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 3.1 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 1.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 3.2 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 2.6 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 1.5 | GO:0033643 | host cell part(GO:0033643) |
0.1 | 0.4 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 2.0 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.4 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 2.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 2.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.4 | GO:0060187 | cell pole(GO:0060187) |
0.1 | 3.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 2.1 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 4.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 3.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 23.2 | GO:0031674 | I band(GO:0031674) |
0.1 | 2.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 1.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 1.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 1.0 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 3.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 3.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 3.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.5 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 6.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 2.7 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 2.1 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.8 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 2.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 1.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.2 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.1 | 1.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 7.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.7 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 2.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.2 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 4.0 | GO:0030017 | sarcomere(GO:0030017) |
0.1 | 1.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 1.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.3 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.1 | 0.6 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 1.5 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 39.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 5.4 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 3.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 1.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 3.6 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 0.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.0 | 0.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 5.4 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 6.7 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 2.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 2.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.0 | 0.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.7 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 2.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 15.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 3.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 2.6 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 0.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 22.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 1.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 1.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 1.7 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.0 | 1.1 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.0 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.6 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 2.9 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 5.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 2.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 1.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 1.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 8.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 2.2 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 1.5 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 1.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 4.0 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 3.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.1 | GO:0001534 | radial spoke(GO:0001534) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.2 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.0 | 0.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.4 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 2.5 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.0 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.0 | 0.5 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 2.2 | GO:0098793 | presynapse(GO:0098793) |
0.0 | 1.0 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.5 | GO:0002102 | podosome(GO:0002102) |
0.0 | 1.4 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.0 | 0.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.1 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.4 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.6 | GO:0031966 | mitochondrial membrane(GO:0031966) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 12.3 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
2.0 | 6.0 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
1.8 | 9.1 | GO:0052836 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
1.8 | 7.3 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
1.8 | 5.4 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
1.6 | 4.9 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.3 | 5.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.2 | 3.7 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
1.1 | 4.2 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
1.0 | 8.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
1.0 | 4.0 | GO:0099609 | microtubule lateral binding(GO:0099609) |
1.0 | 2.9 | GO:0086078 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
0.9 | 8.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.9 | 4.5 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.8 | 4.2 | GO:0005292 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
0.8 | 2.5 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.8 | 2.5 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
0.8 | 3.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.8 | 6.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.8 | 6.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.8 | 2.3 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.7 | 2.9 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.7 | 6.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.7 | 2.6 | GO:0008431 | vitamin E binding(GO:0008431) |
0.6 | 1.9 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.6 | 5.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.6 | 1.9 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
0.6 | 1.8 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.6 | 2.4 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.6 | 2.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 1.7 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.5 | 1.5 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.5 | 0.5 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.5 | 1.5 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.5 | 1.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.5 | 1.8 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.5 | 1.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.4 | 6.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.4 | 2.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 1.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.4 | 2.1 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.4 | 2.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 1.2 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 1.2 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.4 | 1.2 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.4 | 1.2 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.4 | 2.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 2.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.4 | 1.5 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
0.4 | 7.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 1.5 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.4 | 3.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.4 | 1.8 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.4 | 1.4 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.4 | 2.5 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.4 | 1.1 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.4 | 3.6 | GO:0015250 | water channel activity(GO:0015250) |
0.4 | 1.8 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.3 | 2.1 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.3 | 3.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 6.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 1.7 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.3 | 1.0 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 2.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 5.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.3 | 1.9 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.3 | 4.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 0.9 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.3 | 1.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 3.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 7.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.3 | 0.9 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.3 | 9.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 1.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 10.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 1.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.3 | 0.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.3 | 1.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 1.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 0.8 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.3 | 0.8 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
0.3 | 1.1 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
0.3 | 0.8 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.3 | 0.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 0.8 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.3 | 1.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 0.8 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.3 | 0.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 1.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 1.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 1.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 2.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.7 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.2 | 8.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 2.8 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 1.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.2 | 1.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.2 | 5.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 4.6 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 1.5 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.2 | 0.9 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 2.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 1.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 3.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.2 | 1.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.2 | 0.6 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.2 | 0.8 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.2 | 0.6 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.2 | 1.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 1.4 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 5.7 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 4.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 1.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 10.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 2.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.6 | GO:0033961 | cis-stilbene-oxide hydrolase activity(GO:0033961) |
0.2 | 1.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 6.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 2.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 1.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 9.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 1.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.7 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.2 | 2.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 0.5 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.2 | 0.7 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 7.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 1.8 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.2 | 0.9 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.2 | 0.7 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.2 | 1.6 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 0.9 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.2 | 3.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 1.9 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 6.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 0.7 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 1.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 2.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 1.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 1.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 2.0 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 2.5 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.2 | 2.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 1.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.2 | 0.6 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.2 | 0.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 2.8 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 3.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 2.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.1 | 0.6 | GO:0005115 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
0.1 | 0.7 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 1.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 1.0 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.5 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) platelet-derived growth factor beta-receptor activity(GO:0005019) |
0.1 | 1.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 2.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.9 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.1 | 0.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.3 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 2.6 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.6 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 1.1 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 1.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.6 | GO:0033906 | protein tyrosine kinase inhibitor activity(GO:0030292) hyaluronoglucuronidase activity(GO:0033906) |
0.1 | 0.7 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 1.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 3.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.8 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 0.5 | GO:0043813 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.1 | 9.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 1.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 1.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.6 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.1 | 4.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.3 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
0.1 | 0.7 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 1.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.3 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.1 | 0.5 | GO:0000035 | acyl binding(GO:0000035) |
0.1 | 0.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.3 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 1.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 1.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.4 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 1.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.6 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 4.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.3 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
0.1 | 6.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.3 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 1.6 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.5 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 0.7 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 4.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 1.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.8 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.6 | GO:0052841 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.1 | 1.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 1.7 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 1.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.4 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 3.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.7 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.4 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.1 | 1.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.4 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.1 | 1.3 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.2 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.1 | 0.8 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.8 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.2 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.1 | 0.3 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.1 | 0.3 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
0.1 | 0.2 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.1 | 0.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 2.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.0 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 1.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.3 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 1.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.5 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 1.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 6.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.4 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 1.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 1.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 1.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 3.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 1.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.3 | GO:1903135 | superoxide dismutase copper chaperone activity(GO:0016532) cupric ion binding(GO:1903135) |
0.1 | 3.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 1.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.4 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.1 | 0.3 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.1 | 0.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 1.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 1.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.4 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 1.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.4 | GO:1902444 | riboflavin binding(GO:1902444) |
0.1 | 1.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 1.4 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 2.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 1.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.2 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.1 | 7.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.9 | GO:0043295 | glutathione binding(GO:0043295) |
0.1 | 0.7 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.3 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 1.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 1.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.3 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.1 | 0.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 1.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.2 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.4 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.1 | 1.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.1 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 3.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.0 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.0 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 1.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.3 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 0.2 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.0 | 0.8 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 1.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.3 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 3.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 46.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.3 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.2 | GO:0015924 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 2.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 2.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.2 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.3 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 1.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 1.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.3 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.3 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 1.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.0 | 1.0 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.6 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 1.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.0 | 0.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 1.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.7 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.0 | 0.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 1.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 1.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.4 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.0 | 0.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 1.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 4.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.4 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.3 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 0.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 1.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.0 | 0.2 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.0 | 1.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.1 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.0 | 0.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 4.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 1.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 1.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.2 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 0.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 2.4 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.4 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.0 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0004057 | arginyltransferase activity(GO:0004057) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 1.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.2 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.0 | 2.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 2.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.6 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.4 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.1 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.0 | 0.1 | GO:0015039 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.0 | 0.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.0 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 2.2 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.0 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.1 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.0 | 0.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.3 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 1.9 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.6 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.4 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.0 | 1.9 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.5 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.0 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 1.2 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.9 | GO:0015297 | antiporter activity(GO:0015297) |
0.0 | 0.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.4 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 9.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 4.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 4.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 3.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 12.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 18.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 9.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 2.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 2.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 7.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 6.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 6.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 4.6 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 25.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 3.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 6.9 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.3 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 3.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 3.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.5 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 1.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 4.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 2.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 1.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 2.0 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 4.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 1.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 2.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 6.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 9.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 12.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 6.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.4 | 6.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.4 | 9.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 7.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 6.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 13.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 3.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 3.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 2.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 5.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 8.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 2.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 3.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 2.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 5.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 0.7 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 6.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 2.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 2.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 2.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 6.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 4.7 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 3.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 2.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 12.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 6.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 2.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 4.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 10.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 4.4 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 1.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 4.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 5.7 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 1.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 5.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 2.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.8 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 3.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 2.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 5.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 0.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 3.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 4.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 3.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 3.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 1.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 2.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 1.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.0 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 3.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 5.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 2.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 8.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 2.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 1.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 1.6 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 1.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 1.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 1.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 1.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 1.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 1.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 1.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 2.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 7.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.5 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 3.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 1.4 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 5.0 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 1.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 2.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.1 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.0 | 0.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.6 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 3.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |